CANNABIS LEAF EXTRACT,CURCUMA LONGA RHIZOME EXTRACT,HEMP OIL

The combination of Cannabis Leaf Extract, Curcuma Longa Rhizome Extract (commonly known as turmeric), and Hemp Oil has received growing clinical interest for its potential role in managing chronic pain, inflammation, and anxiety-related disorders. Clinical trials have demonstrated favourable outcomes with this plant-based formulation for therapeutic applications, particularly in chronic pain management and inflammation-associated conditions such as arthritis and neuropathy. Research beginning in the early 2000s examined the anti-inflammatory properties of curcumin and cannabinoids, progressing to comprehensive clinical investigations during the 2010s. Regulatory recognition of this combination in select countries reflects findings from these studies, demonstrating its efficacy and safety profile in complementary pain management approaches. As of 2023, countries including Canada, the Netherlands, and certain regions of the U.S. have acknowledged the medical application of this combination within integrative healthcare frameworks.

This combination has been utilised for various therapeutic purposes, including: Chronic Pain Management Inflammatory Disorders Neuropathic Pain Anxiety and Stress Relief Sleep Disorders

The combination is available in various forms, including: Capsules/Tablets : Typically containing 10-25 mg of cannabinoids and 300-500 mg of curcumin per dose. Oils/Tinctures : Administered sublingually with varying concentrations for personalised dosing. Topical Creams : Applied directly to the skin for localised pain relief. Dosage depends on the patient’s condition, weight, and severity of symptoms. A healthcare professional should guide its use for optimal results.

Common side effects may include: Drowsiness Dry mouth Mild gastrointestinal upset Lightheadedness Nausea Severe side effects are rare but may include allergic reactions or liver enzyme elevations.

Psychoactive Effects : Products containing THC may cause mild euphoria, dizziness, or drowsiness. Drug Interactions : May interact with anticoagulants, NSAIDs, and CNS depressants. Pregnancy and Lactation : Not recommended due to insufficient safety data.

Driving and Operating Machinery : Avoid these activities if experiencing drowsiness or dizziness. Allergic Reactions : Monitor for signs of allergies, including rashes, itching, or breathing difficulties. Monitoring : Regular liver function tests are recommended due to potential liver enzyme alterations.

Patients should consult a healthcare professional before using this combination, particularly those taking existing medications or with underlying health conditions. Dosage adjustments or clinical monitoring may be required to ensure safety and efficacy.

https://pubmed.ncbi.nlm.nih.gov/34775634/ https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/research-data/compliance-enforcement-report-cannabis-inspection-data-summary/2023-2024.html https://boheco.com/products/peace-for-mild-chronic-neuropathic-pain-10-capsules-pack-of-1?variant=43999754780885